HYDROXYUREA IN THE TREATMENT OF POLYCYTHEMIA-VERA (A PROSPECTIVE-STUDY OF 100 PATIENTS OVER A 20 YEAR PERIOD)

被引：0
|
作者：
WEST, WO [1 ]
机构：
[1] LEXINGTON CLIN,LEXINGTON,KY
来源：
SOUTHERN MEDICAL JOURNAL | 1986年 / 79卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：27 / 27
页数：1
相关论文
共 50 条
  • [31] Treatment of polycythemia vera: The use of hydroxyurea and pipobroman in 292 patients under the age of 65 years
    Najean, Y
    Rain, JD
    BLOOD, 1997, 90 (09) : 3370 - 3377
  • [32] Treatment Patterns and Blood Counts in Patients With Polycythemia Vera Treated With Hydroxyurea in the United States: An Analysis From the REVEAL Study
    Grunwald, Michael R.
    Kuter, David J.
    Altomare, Ivy
    Burke, John M.
    Gerds, Aaron T.
    Walshauser, Mark A.
    Savona, Michael R.
    Stein, Brady
    Oh, Stephen T.
    Colucci, Philomena
    Parasuraman, Shreekant
    Paranagama, Dilan
    Mesa, Ruben
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (04): : 219 - 225
  • [33] THALAMIC HEMORRHAGE - A PROSPECTIVE-STUDY OF 100 PATIENTS
    KUMRAL, E
    KOCAER, T
    ERTUBEY, NC
    KUMRAL, K
    STROKE, 1995, 26 (06) : 964 - 970
  • [34] HYDROXYUREA DOSING VARIATIONS IN 82 PATIENTS WITH LONG-TERM TREATMENT OF ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA
    Jose Maria, Guerra Hernando
    Ivonne Lizett, Astudillo Romero
    Salas Neus, Amer
    Riera Martin, Mascaro
    Lleonart Juan, Bargay
    Garcia Raquel, Del Campo
    Rodriguez Irene, Vazquez
    Serra Antonia, Cladera
    Perez Delia, Gomez
    Bachs Elena, Gonzlez
    Balanzat Ines, Herraez
    HAEMATOLOGICA, 2021, 106 (10) : 257 - 258
  • [35] TREATMENT OF POLYCYTHEMIA VERA WITH HYDROXYUREA: RATE OF RESPONSE, RESISTANCE/ INTOLERANCE AND EVOLUTIVE COMPLICATIONS IN A SERIES OF 1165 PATIENTS
    Montesdeoca, R. S.
    Kerguelen, A.
    Hernandez Boluda, J. C.
    Perez Encinas, M.
    Araguees, P.
    Ferrer, F.
    Mata, M.
    Redondo, S.
    Gar, V
    Martinez Lopez, J.
    Cuevas, B.
    Barez, A.
    Burgaleta, E.
    De la Fuente, I
    Hernandez Rivas, J. A.
    Xicoy, B.
    Duran, M. A.
    Gomez, M. T.
    Boque, C.
    Caballero, M.
    Besses, C.
    Alvarez Larran, A.
    HAEMATOLOGICA, 2015, 100 : 24 - 24
  • [36] A 2-YEAR PROSPECTIVE-STUDY OF TREATMENT COMPLIANCE IN PATIENTS WITH SCHIZOPHRENIA
    BUCHANAN, A
    PSYCHOLOGICAL MEDICINE, 1992, 22 (03) : 787 - 797
  • [37] MORTALITY AND SURVIVAL IN RHEUMATOID-ARTHRITIS - A 25 YEAR PROSPECTIVE-STUDY OF 100 PATIENTS
    REILLY, PA
    COSH, JA
    MADDISON, PJ
    RASKER, JJ
    SILMAN, AJ
    ANNALS OF THE RHEUMATIC DISEASES, 1990, 49 (06) : 363 - 369
  • [38] LONG-TERM TREATMENT WITH INTERFERON-ALPHA-2B FOR SEVERE PRURITUS IN PATIENTS WITH POLYCYTHEMIA-VERA
    MULLER, EW
    DEWOLF, JTM
    EGGER, R
    WIJERMANS, PW
    HUIJGENS, PC
    HALIE, MR
    VELLENGA, E
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 89 (02) : 313 - 318
  • [39] RUXOLITINIB PROVES SUPERIOR TO BEST AVAILABLE THERAPY IN A PROSPECTIVE, RANDOMIZED, PHASE 3 STUDY (RESPONSE) IN PATIENTS WITH POLYCYTHEMIA VERA RESISTANT TO OR INTOLERANT OF HYDROXYUREA
    Vannucchi, A. M.
    Kiladjian, J. J.
    Griesshammer, M.
    Masszi, T.
    Durrant, S.
    Passamonti, F.
    Harrison, C. N.
    Pane, F.
    Zachee, P.
    Mesa, R.
    He, S.
    Jones, M. M.
    Garrett, W.
    Li, J.
    Francillard, N.
    Habr, D.
    Verstovsek, S.
    HAEMATOLOGICA, 2014, 99 : 790 - 790
  • [40] Hemorrhage in patients with polycythemia vera receiving aspirin with an anticoagulant: a prospective, observational study
    Zwicker, Jeffrey, I
    Paranagama, Dilan
    Lessen, David S.
    Colucci, Philomena M.
    Grunwald, Michael R.
    HAEMATOLOGICA, 2022, 107 (05) : 1106 - 1110
12345